ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,219Medicare Part D Prescriptions Filled, Including Refills

Rank: 236 out of 1107

$667K Total Retail Price of All Prescriptions

Rank: 242 out of 1107

613 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 613 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 613 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,759 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 535 362 1 4
METFORMIN HCL 478 345 2 8
LISINOPRIL 443 293 3 2
LEVOTHYROXINE SODIUM 363 275 4 3
AMLODIPINE BESYLATE 323 253 5 6
LACTULOSE 316 301 6 89
SIMVASTATIN 278 223 7 5
PRAVASTATIN SODIUM 269 189 8 12
FUROSEMIDE 254 187 9 7
POTASSIUM CHLORIDE 231 187 10 14
MIRTAZAPINE 213 153 11 61
FLUTICASONE PROPIONATE 204 128 12 38
DONEPEZIL HCL 178 178 13 32
CITALOPRAM HBR 169 132 14 17
GABAPENTIN 162 108 15 9
TAMSULOSIN HCL 159 125 16 30
ATENOLOL 153 112 17 19
POLYETHYLENE GLYCOL 3350 146 107 18 46
METOPROLOL TARTRATE 145 127 19 10
NAMENDA 137 135 20 42
RISPERIDONE 130 112 21 79
LOSARTAN POTASSIUM 129 83 22 29
HYDROCHLOROTHIAZIDE 124 84 23 11
CLOPIDOGREL 110 93 24 28
CARVEDILOL 108 95 25 27
CARBAMAZEPINE 105 72 26 215
HYDROCODONE-ACETAMINOPHEN 105 103 S3 26 1
PROAIR HFA 99 38 28 37
AZITHROMYCIN 98 67 29 35
PLAVIX 89 70 30 39
MELOXICAM 87 52 31 25
NEXIUM 87 47 31 18
WARFARIN SODIUM 87 66 31 15
GLIMEPIRIDE 86 85 34 43
FLUOXETINE HCL 85 40 35 47
RANITIDINE HCL 84 52 36 21
ISOSORBIDE MONONITRATE ER 82 71 37 34
FAMOTIDINE 82 71 37 111
FINASTERIDE 77 64 39 130
DIGOXIN 76 65 40 52
DIVALPROEX SODIUM 74 40 41 96
CRESTOR 74 57 41 23
LOVAZA 71 54 43 101
TIZANIDINE HCL 67 34 44 73
QUETIAPINE FUMARATE 67 34 44 94
ATORVASTATIN CALCIUM 65 36 46 13
ADVAIR DISKUS 65 36 46 54
NYSTATIN 64 42 48 110
DOXAZOSIN MESYLATE 61 35 49 92
PANTOPRAZOLE SODIUM 61 36 49 30
BENZTROPINE MESYLATE 60 31 R 51 174
NOVOLOG MIX 70-30 59 38 52 264
RISPERDAL CONSTA 57 57 53 263
ALBUTEROL SULFATE 57 48 53 144
CEFUROXIME 57 41 53 157
CYMBALTA 56 26 56 50
LYRICA 54 16 57 83
AMITRIPTYLINE HCL 53 24 R 58 48
TRAZODONE HCL 52 45 59 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 37 60 24
LEVETIRACETAM 51 47 60 141
SPIRIVA 51 22 60 57
LANTUS 50 25 63 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.